This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN inched 0.44% higher to $2.27 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.88% to 3,785.38 and Dow Jones Industrial Average DJIA falling 0.82% to 30,775.43. This was the stock's second consecutive day of gains. Ocugen Inc. closed $15.38 short of its 52-week high ($17.65), which the company reached on November 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Adverum Biotechnologies Inc. ADVM rose 1.69% to $1.20, Ocular Therapeutix Inc. OCUL rose 3.34% to $4.02, and Kodiak Sciences Inc. KOD fell 3.54% to $7.64. Trading volume (5.0 M) remained 2.0 million below its 50-day average volume of 7.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 30, 2022.
(END) Dow Jones Newswires
June 30, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.